News about Drug Discovery & Development

Streck, Longhorn Vaccines and Diagnostics to Distribute PrimeStore MTM Globally

Streck has joined forces with Longhorn Vaccines and Diagnostics to distribute its flagship product, PrimeStore Molecular Transport Media (MTM), worldwide.

Drug Discovery & Development | 12/06/2024 | By Aishwarya |  320

ALZpath Signs Licensing Deal with Roche for Use of pTau217 Antibody in Blood Test

ALZpath, Inc. has signed a strategic license agreement with Roche for the use of the ALZpath pTau217 antibody to develop and commercialize an Alzheimer's disease diagnostic blood test.

Drug Discovery & Development | 11/06/2024 | By Aishwarya |  917

Amneal Expands Broad Injectables Portfolio with Addition of Six New Therapies

Amneal Pharmaceuticals has expanded its injectables portfolio with six new injectable product launches during the second quarter of 2024.

Drug Discovery & Development | 11/06/2024 | By Aishwarya |  643

Orchid Pharma Gets DCGI Approval for Enmetazobactam

Orchid Pharma has secured Drugs Controller General of India (DCGI) approval for the manufacturing and marketing of its invented New Chemical Entity Active Pharmaceutical Ingredient (API), Enmetazobactam.

Drug Discovery & Development | 10/06/2024 | By Aishwarya |  839

Saghmos Gets US Patent for Phase 3-Ready Cardiorenal Metabolic Modulator

Saghmos Therapeutics, Inc. has announced that the US Patent and Trademark Office (USPTO) has granted US Patent No. 11,986,473 titled, 'Prevention and/or Treatment of Contrast-Induced Acute Kidney Injury' for its Phase 3-ready product, ST-62516.

Drug Discovery & Development | 06/06/2024 | By Aishwarya |  613

Lupin Gets Tentative Approval from US FDA for Letermovir Tablets

Lupin has secured a tentative approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Letermovir Tablets, 240 mg and 480 mg, to market a generic equivalent of Prevymis Tablets, 240 mg and 480 mg, of Merck Sharp & Dohme LLC.

Drug Discovery & Development | 05/06/2024 | By Aishwarya |  1166

Syngene Rolls Out New Platform for Enhanced Protein Production

Syngene International Ltd. has introduced its new protein production platform.

Drug Discovery & Development | 05/06/2024 | By Aishwarya |  776

Bionova Scientific to Expand New Plasmid DNA GMP Facility

Bionova Scientific has decided to expand into plasmid DNA (pDNA) production.

Drug Discovery & Development | 04/06/2024 | By Aishwarya |  702

Telix Completes TLX250-CDx BLA Submission for Kidney Cancer Imaging

Telix Pharmaceuticals has completed the submission of a Biologics License Application (BLA) to the United States (US) Food and Drug Administration (FDA) for its investigational radiodiagnostic PET agent.

Drug Discovery & Development | 03/06/2024 | By Aishwarya |  417

GRIT and Quangang to Boost Localization of Interleukin-2

Shanghai Grit Biotechnology Co., Ltd. (GRIT) has forged a formal strategic partnership with Shandong Quangang Pharmaceutical Co., Ltd. (Quangang) to leverage both parties' R&D capabilities in innovative T-cell therapy.

Drug Discovery & Development | 01/06/2024 | By Aishwarya |  495